NCT04512443View on ClinicalTrials.gov

Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

December 28, 2019

Primary Completion Date

March 28, 2020

Study Completion Date

March 28, 2020

Conditions
Pelvic Congestion Syndrome
Interventions
DRUG

Daflon

All consecutive patients were randomly allocated into 2 groups to receive Daflon (Detralex) at a dose of 1000 mg once daily (study group) or placebo (control group).

Trial Locations (2)

420097

Akhmetzianov Rustem, Kazan'

Unknown

Roman Bredikhin, Kazan'

All Listed Sponsors
lead

Interregional Clinical Diagnostic Center, Russia

OTHER

NCT04512443 - Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome | Biotech Hunter | Biotech Hunter